FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Non-Small Cell Lung Cancer · Colorectal Cancer · Breast Cancer · Ovarian Cancer · Endometrial Carcinoma · Head and Neck Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Southern California, La Jolla, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Study coordinator (Principle Investigator)Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Principle Investigator)M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Principle Investigator)
Study leads
Brian Dempster
Study Director
Fate Therapeutics